PFE — PFIZER INC
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 78003 ·
Last close
$28.47
Market Cap
$162.27B
52W High
$30.99
52W Low
$22.76
ADV30
34,163,674
Next earnings
2027-02-02
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 15,034,000,000 | 10,942,000,000 | 3,537,000,000 | -248,000,000 | 201,131,000,000 | 976,000,000 | 115,639,000,000 |
| Mar 2026 | 14,450,000,000 | 10,902,000,000 | 4,268,000,000 | 2,687,000,000 | 207,618,000,000 | 1,703,000,000 | 117,214,000,000 |
| Dec 2025 | 17,557,000,000 | 12,285,000,000 | 3,687,000,000 | -1,648,000,000 | 208,160,000,000 | 1,142,000,000 | 121,385,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$14,176,000,000
Investing CF
$-5,281,000,000
Financing CF
$-8,428,000,000
CapEx
$-2,387,000,000
Dividends Paid
$-9,792,000,000
Buybacks
—
EPS Diluted TTM
$0.70
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$115,328,000,000
Inventory
$10,022,000,000
Receivables
$17,567,000,000
ST Investments
$12,448,000,000
EBIT TTM
$6,968,000,000
Pretax Income TTM
$4,260,000,000
Interest Exp TTM
$2,708,000,000
Analysts
26
Yahoo Snapshot (yfinance, live)
Total Revenue
$63,623,999,488
EBITDA
$24,937,000,960
Free Cash Flow
$13,006,999,552
Enterprise Value
$216,946,704,384
Total Cash
$14,279,000,064
Total Debt
$63,408,001,024
Shares Out
5,699,853,733
Trailing EPS
$0.70
Book Value
$15.61
ROE
4.5%
ROA
5.6%
Div Yield
5.85%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 62,579,000,000 | 17,407,000,000 | 7,771,000,000 | 208,160,000,000 | 121,385,000,000 | 86,476,000,000 | 11,704,000,000 |
| Dec 2024 | 63,627,000,000 | 14,938,000,000 | 8,031,000,000 | 213,396,000,000 | 124,899,000,000 | 88,203,000,000 | 12,744,000,000 |
| Dec 2023 | 59,554,000,000 | 4,417,000,000 | 2,119,000,000 | 226,501,000,000 | 137,213,000,000 | 89,014,000,000 | 8,700,000,000 |
| Dec 2022 | 101,175,000,000 | 38,117,000,000 | 31,372,000,000 | 197,205,000,000 | 101,289,000,000 | 95,661,000,000 | 29,267,000,000 |
TTM Snapshot
Revenues TTM
$63,696,000,000
NetIncome TTM
$4,333,000,000
OpCashFlow TTM
—
Assets (Latest)
$201,131,000,000
Forward EPS
$2.94
Max Pain — expiry 2026-11-27 (volume-derived — Yahoo OI feed degraded)
max pain strike: $29.00 · spot: $28.06 · call volume: 23,247 · put volume: 2,274
Expected Move to 2026-11-27:
±$0.88
(3.14%) —
implied range
$27.18 –
$28.94
· ATM straddle on $28.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | $181.35B | $104.71 | — |
| NVO | NOVO NORDISK A S | $136.10B | $40.70 | — |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $135.44B | $534.20 | — |
| BMY | BRISTOL MYERS SQUIBB CO | $125.40B | $61.35 | — |
| SNY | Sanofi | $113.89B | $47.53 | — |
News headlines (Yahoo Finance, 1h cache)
Pfizer leaps into ‘in vivo’ CAR-T with latest China deal
2026-11-18 15:55 · Yahoo
Global Medical Countermeasures Market 2026: Size, Trends, and Forecast to 2030 | Capitalize on AI, Stockpiling, and Rapid Diagnostics with Pfizer, Moderna, Sanofi, and Emergent
2026-11-18 14:36 · Yahoo
Pfizer Enters into Exclusive Licensing Agreement with Starna Therapeutics for Autoimmune Diseases
2026-11-18 11:45 · Yahoo
A 67-Year-Old With $750,000 in Pfizer, Enterprise Products and UPS Collects $3,765 a Month in Dividends. How Safe Is Each Check?
2026-11-17 19:50 · Yahoo
Wall Street Forgot These 3 Dividend Stocks — Now They Pay Over 5%
2026-11-17 19:20 · Yahoo
Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in Revenue
2026-11-17 18:50 · Yahoo
Conagra Cut Its Dividend 50%. The Stock Market Was Warning Investors
2026-11-17 17:47 · Yahoo
Pfizer CEO: ‘China will be my major competition by 2030’
2026-11-17 16:58 · Yahoo
Drug and Gene Delivery Devices - Global Strategic Business Report 2026: Capitalize on 8.1% CAGR to Secure the $1.2 Billion Market by 2032 as AbbVie, Moderna, Pfizer and Novartis Accelerate
2026-11-17 15:02 · Yahoo
3 High-Yield Dividend Stocks Down Nearly 30% or More in 5 Years
2026-11-18 13:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.